Complex Generic / 505(b)(2) Pipeline
Various (Oncology, Immunology, and other areas)
Pre-clinical to Phase 3 (Bioequivalence)Active
Key Facts
Indication
Various (Oncology, Immunology, and other areas)
Phase
Pre-clinical to Phase 3 (Bioequivalence)
Status
Active
Company
About GenZum Life Sciences
Genzum Life Sciences is a private, US-based pharmaceutical development company specializing in complex generics and 505(b)(2) products, with a core focus on topical and sterile formulations. Founded in 2018, it operates as a product development and out-licensing partner, co-investing with commercial partners to bring difficult-to-develop products to market. The company leverages a team of industry veterans to manage development from formulation through Phase III studies, aiming to reduce drug costs and create market value through strategic global partnerships.
View full company profile